Linking a Type 2 Drug to Too Much Acid in the Blood
The U.S. Food and Drug Administration (FDA) recently announced that sodium-glucose cotransporter-2 (SGLT2) inhibitors may be linked to cases of increased levels of acid in the blood. Sam Grossman talks about the FDA’s reporting on this subject.